Innovating with AI: Drive Techco Value Creation to New Heights
BARCELONA, Spain, March 7, 2025 /PRNewswire/ -- James Chen, President of Huawei…
Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe…
